Mimedx (MDXG) EPS (Basic) (2011 - 2026)

Mimedx has disclosed EPS (Basic) across 16 years of filings, most recently posting -$0.1 for Q2 2026.

• In Q2 2026, EPS (Basic) fell 254.26% year-over-year to -$0.1; the TTM figure through Jun 2026 stood at $0.04 (down 80.48% YoY), while the FY2025 annual figure was $0.33, up 15.03% from the prior year.
• EPS (Basic) came in at -$0.1 for Q2 2026 at Mimedx, down from -$0.07 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $0.38 in Q4 2023 to a low of -$0.11 in Q2 2022.
• Average EPS (Basic) over 5 years is $0.04, with a median of $0.06 recorded in 2023.
• The largest YoY upside for EPS (Basic) was 668.66% in 2022 against a maximum downside of 272.68% in 2022.
• Over 5 years, EPS (Basic) stood at $0.07 in 2022, then surged by 434.16% to $0.38 in 2023, then tumbled by 86.85% to $0.05 in 2024, then jumped by 103.11% to $0.1 in 2025, then sank by 197.69% to -$0.1 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were -$0.1 in Q2 2026, -$0.07 in Q1 2026, and $0.1 in Q4 2025.